Analysts' Upgrades, Downgrades: H-P

See who made what calls.

Author:: TSC Staff
Publish date:: May 20, 2009 9:53 AM EDT

See who made what calls.

CHANGE IN RATINGS

Analog Devices

(ADI) - Get Report

upgraded at Deutsche Bank from Hold to Buy. $26 price target. Leverage story is just beginning to unfold.

Analog Devices

(ADI) - Get Report

numbers raised at Barclays through 2010. Company is a good defensive stock, because of its limited PC exposure. Overweight rating and new $22 price target.

Analog Devices

(ADI) - Get Report

target raised at Credit Suisse to $23 from $16 following strong Q2 results and guidance. Maintained Neutral rating.

Biogen Idec

(BIIB) - Get Report

upgraded at Barclays from Underweight to Equal-weight. $52 price target. Tysabri utilization has been rising, and the company could exceed near-term earnings expectations.

Colgate

(CL) - Get Report

downgraded at Barclays. Rating lowered to Equal Weight from Overweight. Price target lowered to $68 from $71. Maintains 2009 EPS estimates of $4.23.

Costco

(COST) - Get Report

upgraded at Credit Suisse to Outperform from Neutral based on valuation. Stock is trading at a discount to its normal multiple. Raised target price to $55 from $39.

Home Depot

(HD) - Get Report

downgraded at Friedman, Billings Ramsey from Outperform to Market Perform. $25 price target. Company is now starting to hurt from the acceleration of foreclosure activity.

Home Depot

(HD) - Get Report

estimates, target increased at Barclays through 2010. Company is seeing better sales and keeping a tight lid on costs. Overweight rating and new $26 price target.

Kansas City Southern

(KSU) - Get Report

upgraded at Merrill/BofA from Neutral to Buy. $21 price target. Valuation call, as the worst of the company's balance sheet concerns have passed. Liquidity also appear sustainable.

McDonald's

(MCD) - Get Report

upgraded at Deutsche Bank from Hold to Buy. $65 price target. Company generates attractive cash flow and has several potential upcoming catalysts.

Procter & Gamble

(PG) - Get Report

upgraded at Barclays to overweight from equal weight and price target increased to $60 from $56. Barclays believes it is time to re-embrace its long term +3-5% organic revenue growth and revisit how it chooses to spend its investment dollars.

Royal Dutch Shell

(RDS)

upgraded at JPMorgan to Neutral from Underweight based on valuation and recent underperformance in the stock. Believe weak macroeconomic outlook is priced in and high dividend will be maintained.

TJX Companies

(TJX) - Get Report

upgraded at MKM from Neutral to Buy. $35 price target. Stock remains undervalued, despite the recent rebound.

Tyson Foods

(TSN) - Get Report

upgraded at Keybanc from Hold to Buy. $16 price target. Earnings visibility has improved in the Chicken segment.

Zoran

(ZRAN)

upgraded at JPMorgan to Neutral from Underweight based on stabilizing consumer electronics market and improving visibility. Management made positive comments on near-term demand and profitability in Q3. Price target raised to $10 from $7.50.

STOCK COMMENTS / EPS CHANGES

Campbell Soup

(CPB) - Get Report

numbers cut at Morgan Stanley through 2011. Company is seeing lower soup sales. Equal-weight rating and new $28 price target.

Dick's Sporting Goods

(DKS) - Get Report

numbers upped at Barclays to $19. Estimates also increased, to reflect improved sales and better expense management. Overweight rating.

Hewlett-Packard

(HPQ) - Get Report

numbers increased at Barclays to $42. Estimates also raised, to reflect cost cuts and a more stable economy. Overweight rating.

Kellogg

(K) - Get Report

estimates, target raised at Morgan Stanley to $48. Estimates also increased, as the company is positioned well against several industry headwinds. Overweight rating.

Kimberly-Clark

(KMB) - Get Report

target cut at Barclays to $54 a share. Company will likely trade at a discount to its peers. Equal-weight rating.

Medtronic

(MDT) - Get Report

estimates lowered at UBS through 2010. CRDM business is losing market share and a drag on growth. Buy rating and $49 price target.

McAfee

(MFE)

target raised at Morgan Stanley to $43. Pipeline and sales trends were strong through May, and consumer growth should continue. Overweight rating.

Scotts Miracle-Gro

(SMG) - Get Report

numbers raised at Jefferies to $45. Estimates also increased, as favorable consumer business trends have continued into May. Buy rating.